The challenges and trends of cell & gene therapiesÂ
Drug Discovery World
SEPTEMBER 6, 2022
Unsurprisingly, oncology remains the biggest focus for cell and gene therapy developers, accounting for 52% of clinical activity in 2021, according to ARM’s Regenerative Medicine: Disrupting the Status Quo report. Last year saw the sector surge, with levels of investment hitting an all-time high at $22.7 billion, compared to $19.9
52 
Let's personalize your content